Microvessel Density (MVD) in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis

Cancer Invest. 2024 Jan;42(1):104-114. doi: 10.1080/07357907.2024.2311266. Epub 2024 Feb 12.

Abstract

A meta-analysis was designed and conducted to estimate the effect of tumoral microvessel density (MVD) on the survival of patients with osteosarcoma. There was no difference between high and low MVD regarding the overall (OS) and disease-free (DFS) survival. Low MVD tumors displayed a lower DFS at the third year of follow-up. Although primary metastases did not affect the mean MVD measurements, tumors with a good chemotherapy response had a higher MVD value. Although no significant differences between tumoral MVD, OS and DFS were found, good adjuvant therapy responders had a significant higher vascularization pattern.

Keywords: Microvessel; angiogenesis; density; meta-analysis; osteosarcoma.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Bone Neoplasms* / therapy
  • Combined Modality Therapy
  • Disease-Free Survival
  • Humans
  • Microvascular Density
  • Neovascularization, Pathologic
  • Osteosarcoma* / drug therapy
  • Prognosis